Brain cancer known as a malignant brain tumor, in the medical definition, is a cancer that is most threatening of all human cancers. Using a variety of supporting Proteomics approach, we can easily detect and genetic analysis of the effects of certain activities that are involved in the development of malignant brain cancer.
In General, we are supporting proteomics study proteomes. Proteome can be referred to as protein genome compliment. A malignant Tumor of the brain are generally classified into four classes, according to their complexity or level based on their physical appearance under a microscope.
The term is generally used when brain cells shows the physical appearance of their cells were similar to normal. Simple, it is like a benign tissue or cells.
Cells were more violent start to proliferation. In 3rd grade, they tend to grow rapidly and began attacking in almost normal cells are located. This situation is known as Anaplastic, in medical terms. Cancer cells can break away from a tumour and began to spread, perhaps to other parts of the brain or spinal cord.
Generally, brain cancer cells have a variety of abnormal proteins. They express altered genetic potential of cancer cells. These are examples of relevant transgenic proteins as well as regulated protein after their synthesis.
The interpretation of the genetic modification in the level of different types of brain cancer are brain stem glioma, medulloblastoma, ependymoma, juvenile pilocytic, oligodendroglioma, meningiomas, can be done easily by using other tools supporting proteomics.
These different techniques to basically act on the property modification of abnormal protein that is extracted from the cancer cells of a malignant tumor.
Bio-engineered approach to supporting Proteomics biomarkers analysis has allowed new brain cancer variety. A concise interpretation of the truth of every marker of brain cancer would be very helpful in detecting the level or a variant of that malignant cells in certain contexts.
Cancer Biomarkers research will explore new ways to get the options associated with the various alternative therapies. Finally, it will represent a new approach to biological research in the era of the upcoming clinical or rapid detection of brain cancer.